Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure
Clinical trial NCT02032004 · COMPLETED
Trial details
- NCT number
- NCT02032004
- Sponsor
- Mesoblast, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-03
- Primary completion
- 2020-01-30
- Enrollment
- 565
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.